Skip to content
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboardSign in
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboard
Sign in
Transparency
  • Company
  • Our clinicians
  • Pharmacy partners
  • Where we operate
  • Accreditation
Legal
  • Terms of Service
  • Privacy Policy
  • Notice of Privacy Practices
  • Telehealth Consent
  • Auto-Renewal Terms
  • Refund & Shipping
  • Pharmacy Disclosure
  • Prescribing Policy
  • Patient Rights & Nondiscrimination
  • Texas Medical Board Complaint Notice
  • SMS Terms
  • Cookies
  • California Privacy
  • Accessibility
Support
  • support@upliftrx.co
  • Member sign in

Medical emergency? Call 911. In crisis? Call or text 988 (Suicide & Crisis Lifeline). UpLiftRX is not for emergencies.

Prescription products require an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Available to adults 18+ in states where our clinicians are licensed.

Compounded medications are prepared by state-licensed pharmacies for an individual patient and are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX provides a technology platform and is not a pharmacy or a medical provider. Medical services are provided by independent, licensed clinicians of a professional medical group (being finalized). Prescriptions are dispensed by independent, state-licensed pharmacies. Latitude Investments Management Ltd. Liability Co., a Wyoming limited liability company (filing no. 2024-001499647), 5709 Gardendale Dr, STE D, Houston, TX 77092.

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® and Cialis® are registered trademarks of Eli Lilly and Company. Contrave® is a registered trademark of Currax Pharmaceuticals LLC. Viagra® is a registered trademark of Viatris Specialty LLC. All trademarks are the property of their respective owners. UpLiftRX is not affiliated with or endorsed by any drug manufacturer, and generic medications are not the brand-name products.

© 2026 Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX.
  1. Home/
  2. Medications/
  3. Appetite Suppressant/
  4. Orforglipron + Pyridoxine (B6)
Orforglipron + Pyridoxine (B6) oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Appetite Suppressant

Orforglipron + Pyridoxine (B6) Capsule

Capsule6 variations

Orforglipron capsule with pyridoxine (vitamin B6). Foundayo (orforglipron) tablets were approved in 2026 for chronic weight management. This capsule is not one of those tablet strengths.

$75/ month· visit, medication & shipping · charged only if prescribed
Choose a variation
Just this one: start consultation

Add several treatments and check out once. $0 today; each is charged only if prescribed.

Rx only · adults 18+. Requires an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Compounded medications are prepared by a state-licensed pharmacy and are not FDA-approved.

Know before you start

How Orforglipron + Pyridoxine (B6) treatment works

How it works

GLP-1 (and dual/triple agonist) medications mimic gut hormones that regulate appetite and blood sugar. They slow stomach emptying and act on appetite centers in the brain, helping you feel full sooner and stay full longer — so sustainable calorie reduction stops being a willpower fight.

What to expect

  • Weeks 1–4: dose titration begins low to minimize nausea; appetite typically quiets noticeably.
  • Months 2–3: dose adjusts based on response and tolerance at your check-ins.
  • Ongoing: monthly shipments, message your care team anytime, labs as clinically indicated.

Common side effects

  • Nausea (most common, usually improves after the first weeks)
  • Constipation or diarrhea
  • Fatigue or headache during titration
  • Injection-site irritation

Safety & who it's not for

Not for patients with a personal/family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or who are pregnant, breastfeeding, or trying to conceive. Your clinician screens for these and more during intake.

Orforglipron + Pyridoxine (B6) FAQ

What is Orforglipron + Pyridoxine (B6)?

Orforglipron capsule with pyridoxine (vitamin B6). Foundayo (orforglipron) tablets were approved in 2026 for chronic weight management. This capsule is not one of those tablet strengths. It is compounded for you by a state-licensed 503A pharmacy and is not FDA-approved.

How much does Orforglipron + Pyridoxine (B6) cost?

Orforglipron + Pyridoxine (B6) starts at $75 per month through UpLiftRX. The price includes the online clinician visit, the medication, and shipping. Your card is charged only if a licensed clinician prescribes it. Price depends on the strength and size you are prescribed (6 options).

What strengths of Orforglipron + Pyridoxine (B6) are available?

Orforglipron + Pyridoxine (B6) is available as 1 mg / 2 mg 30 capsules, 3 mg / 2 mg 30 capsules, 7 mg / 2 mg 30 capsules, 12 mg / 2 mg 30 capsules, 24 mg / 2 mg 30 capsules and 36 mg / 2 mg 30 capsules. Your clinician chooses the strength and dose.

How is Orforglipron + Pyridoxine (B6) taken?

Orforglipron + Pyridoxine (B6) is taken by mouth. Typical pharmacy directions read: "Take 1 capsule (3 mg/2 mg) by mouth once daily." Your clinician sets your actual dose and schedule, and the pharmacy label on your prescription is what you follow.

Is Orforglipron + Pyridoxine (B6) FDA-approved?

No. Orforglipron + Pyridoxine (B6) is a compounded preparation, and compounded drugs are not FDA-approved. FDA has approved other products that contain orforglipron (for example Foundayo); a compounded version is prepared for an individual patient when a clinician decides it is appropriate.

Do I need a prescription for Orforglipron + Pyridoxine (B6)?

Yes. Orforglipron + Pyridoxine (B6) requires a prescription. Start an online visit, answer the health questionnaire, and a licensed clinician reviews it. If Orforglipron + Pyridoxine (B6) is appropriate, the clinician prescribes it and a licensed pharmacy ships it to you.

How should I store Orforglipron + Pyridoxine (B6)?

Store at room temperature, away from heat and moisture.

Where does Orforglipron + Pyridoxine (B6) ship?

Pharmacies in our network can ship Orforglipron + Pyridoxine (B6) to 35 states and DC (not California). It is not currently available in 15 states; the online visit checks your state first. Orders typically arrive in 1 day after the pharmacy ships, and shipping is included in the price.

What does the research say about Orforglipron?

PubMed indexes 145 publications that mention Orforglipron, including 46 randomized trials, systematic reviews, or meta-analyses. ClinicalTrials.gov lists 53 registered studies. Study results for FDA-approved products do not transfer automatically to compounded preparations. The sources are linked on this page.

Do I need to diet and exercise too?

These medications work best alongside basic nutrition and activity habits. Your clinician will set realistic expectations — most members find the medication makes those habits dramatically easier to keep.

Is compounded medication the same as the brand?

Compounded drugs are not FDA-approved and are not generic or automatically equivalent to an approved product. When compounding is clinically appropriate and legally available, the exact ingredient form, concentration, route, source, and dispensing facility must be independently verified.

What happens if I stop?

Appetite typically returns toward baseline. Many members taper with their clinician's guidance and keep results with maintenance habits; others stay on a maintenance dose.

Important safety information

Your clinician will review your health history, current medications, and allergies and explain the risks, side effects, and alternatives before prescribing.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before they are dispensed. Tell your clinician about all medications and supplements you take. Seek emergency care (call 911) for severe reactions. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Similar products

Similar to Orforglipron + Pyridoxine (B6)

See all in Appetite Suppressant →
Wegovy® (semaglutide) injectable, brand-name prescription medication, pharmacy prescription bag illustrationBrand-name · FDA-approved
Appetite Suppressant
Wegovy® (semaglutide)
5 options
Zepbound® (tirzepatide) injectable, brand-name prescription medication, pharmacy prescription bag illustrationBrand-name · FDA-approved
Appetite Suppressant
Zepbound® (tirzepatide)
6 options
Contrave® (naltrexone/bupropion ER) oral, brand-name prescription medication, pharmacy prescription bag illustrationBrand-name · FDA-approved
Appetite Suppressant
Contrave® (naltrexone/bupropion ER)
8mg/90mg
Saxenda® (liraglutide) injectable, brand-name prescription medication, pharmacy prescription bag illustrationBrand-name · FDA-approved
Appetite Suppressant
Saxenda® (liraglutide)
18mg/3mL (0.6–3mg daily)
$75/mo
On this pageOverviewStrengths & pricesHow it's takenStorage & shippingResearch & sourcesFAQReviewsSafety
At a glance

What is Orforglipron + Pyridoxine (B6) Capsule?

Orforglipron + Pyridoxine (B6) is a compounded capsule prepared for an individual patient by a state-licensed 503A compounding pharmacy. It is not FDA-approved. It is available in 6 strength and size options. Route: by mouth. Through UpLiftRX it costs from $75 per month, including the online visit, the medication, and shipping. You are charged only if a licensed clinician prescribes it. It can ship to 35 states and DC (not California).

Form
Capsule
Route
By mouth
Active ingredients
Orforglipron, Pyridoxine (B6)
Options
6 strength and size options
Price
$75 to $600 per month, visit and shipping included
Prescription
Required. A licensed clinician decides whether it is appropriate.
FDA status
Compounded. Not FDA-approved; FDA does not review compounded drugs before they are dispensed.
Dispensed by
A state-licensed 503A compounding pharmacy
Ships to
35 states and DC (not California)
Storage
Store at room temperature, away from heat and moisture.
Availability
In stock at one or more pharmacies

Product details from our pharmacy network's catalog, updated October 22, 2026.

Strengths & prices

Orforglipron + Pyridoxine (B6) Capsule strengths and prices

6 options. Prices are per month and include the online visit, the medication, and shipping; you are charged only if a clinician prescribes it.
StrengthSizePriceAvailability
1 mg / 2 mg30 capsules$75In stock
3 mg / 2 mg30 capsules$95In stock
7 mg / 2 mg30 capsules$145In stock
12 mg / 2 mg30 capsules$275In stock
24 mg / 2 mg30 capsules$370In stock
36 mg / 2 mg30 capsules$600In stock
How it's taken

How to take Orforglipron + Pyridoxine (B6) Capsule

Route and directions

Route: By mouth

Example pharmacy label: “Take 1 capsule (3 mg/2 mg) by mouth once daily.”

Your clinician sets your dose and schedule. Follow the label on your own prescription, not this example.

Preparation and supplies

Mixing: None. It ships ready to use.

Storage & shipping

Storing and shipping Orforglipron + Pyridoxine (B6) Capsule

Storage

Store at room temperature, away from heat and moisture.

Keep out of reach of children. Do not use after the beyond-use date on the label.

Shipping

Ships to 35 states and DC (not California), typically arriving in 1 day after the pharmacy ships. Shipping is included in the price.

States it ships to

Alaska, Alabama, Arizona, Colorado, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Louisiana, Maryland, Maine, Minnesota, Missouri, Montana, North Dakota, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Dakota, Texas, Utah, Vermont, Washington, Wisconsin, Wyoming

Clinical research & sources

Research on the ingredients in Orforglipron + Pyridoxine (B6) Capsule

Published research and public drug references for each active ingredient, from the U.S. National Library of Medicine (PubMed, MedlinePlus, DailyMed, RxNorm, PubChem), ClinicalTrials.gov, and FDA. These studies are about the ingredients, often in FDA-approved products. None of them tested this compounded preparation, and their results do not automatically apply to it.

Orforglipron

FDA status: FDA has approved products that contain orforglipron, including Foundayo.

PubMed: 145 publications mention Orforglipron, 46 of them trials or reviews. Search PubMed

  1. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. Wharton S et al. The New England journal of medicine, 2025. Randomized Controlled Trial, Clinical Trial, Phase III. PMID 40960239 · DOI
  2. Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial. Rosenstock J et al. Lancet (London, England), 2026. Clinical Trial, Phase III, Randomized Controlled Trial. PMID 41765029 · DOI
  3. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Rosenstock J et al. The New England journal of medicine, 2025. Randomized Controlled Trial, Clinical Trial, Phase III. PMID 40544435 · DOI
  4. Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis. Nong K et al. BMJ (Clinical research ed.), 2026. Systematic Review, Network Meta-Analysis. PMID 42419792 · DOI
  5. Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants. Pratt E et al. Diabetes, obesity & metabolism, 2023. Randomized Controlled Trial, Clinical Trial, Phase I. PMID 37344954 · DOI

ClinicalTrials.gov: 53 registered studies. See all studies

  • NCT05803421 A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (Phase 3), completed
  • NCT07241390 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) (Phase 3), recruiting

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 2739838 ↗PubChem CID 137319706 ↗Wikipedia ↗

Pyridoxine

FDA status: FDA has approved products that contain pyridoxine, including Bonjesta, Diclegis, Infuvite Pediatric.

PubMed: 7,199 publications mention Pyridoxine, 302 of them trials or reviews. Search PubMed

  1. ESPEN micronutrient guideline. Berger MM et al. Clinical nutrition (Edinburgh, Scotland), 2022. Meta-Analysis. PMID 35365361 · DOI
  2. Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures. Pressler RM et al. Epilepsia, 2023. Systematic Review, Meta-Analysis. PMID 37655702 · DOI
  3. Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review. McParlin C et al. JAMA, 2016. Systematic Review. PMID 27701665 · DOI
  4. Leg cramps. Young G et al. BMJ clinical evidence, 2015. Systematic Review. PMID 25970567
  5. The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review. Muhamad R et al. , 2023.

Sources checked October 22, 2026. Listing a study is not a claim that this product is safe or effective for you; a licensed clinician makes that decision.

Patient reviews

Reviews come only from patients who received Orforglipron + Pyridoxine (B6) Capsule through UpLiftRX. Each is checked for privacy and safety before it's published; we never remove a review for being negative. Individual experiences vary, and reviews aren't medical advice.

No reviews yet. Patients who receive Orforglipron + Pyridoxine (B6) Capsule through UpLiftRX can leave a review after delivery.

For patients who received Orforglipron + Pyridoxine (B6) Capsule.
Nutrients
Systematic Review.
PMID 37447150
· DOI

ClinicalTrials.gov: 387 registered studies. See all studies

  • NCT03905564 A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions (Phase 1), withdrawn

MedlinePlus drug information ↗RxNorm 684879 ↗PubChem CID 1054 ↗Wikipedia ↗